Latest Nzx News

Marlin Global delivered a 4.0% gross portfolio return in April 2026, driven by strong gains in AI-focused tech stocks like Amazon and Alphabet. However, its cautious stance on semiconductors limited upside amid a sector rally.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.

AoFrio’s first quarter revenue plunged 28% year-on-year, weighed down by the loss of a major US motor customer amid tariffs. The refrigeration tech firm is banking on new IoT product launches in Q2 to stabilise sales and improve profitability over 2026.

Radius Residential Care delivered a standout FY26 with profit before tax surging 37% to $14.3 million, a 50% hike in its final dividend, and growth fueled by acquisitions and new developments.

Comvita has completed a $40.5 million capital raise combining a $30 million Rights Offer and a $10.5 million Strategic Placement, welcoming Singapore’s F&N Ventures as a near 20% strategic investor.

Property for Industry Limited (NZX: PFI) announced a 10.5% upgrade to its full-year FY26 dividend guidance, now targeting approximately 9.50 cents per share, supported by stable cash flows and controlled capital expenditure.

Manuka Resources completes early-stage Mt Boppy drilling with low-grade gold results but gains key structural insights, while launching resource definition drilling at Pipeline Ridge targeting a maiden gold resource.

Accordant Group has closed its pro rata renounceable rights offer, securing NZD 5 million and increasing the Hull Family Trust's voting stake to nearly 65%.

Santana Minerals has corrected its timeline for settling the purchase of 3,680 hectares for its Bendigo-Ophir Project, extending the deadline to the earlier of mid-2030 or 12 months after mining consents are granted.

Pacific Edge is raising NZ$24 million to shore up its finances and support a crucial Medicare re-coverage bid following a steep revenue drop after losing Medicare reimbursement for its bladder cancer test. The company eyes a draft Medicare policy by September 2026 as a potential turning point.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.